Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 7;31(2):192-198.
doi: 10.5606/tgkdc.dergisi.2023.24422. eCollection 2023 Apr.

The impact of the apelinergic system in coronary collateral formation

İbrahim Özsoyler  1 , Haci Ali Uçak  1 , Tolga Onur Badak  1 , Ahmet Çakallıoğlu  1 , Muhammet Bayraktar  2 , Ahmet Süha Arslan  1
Affiliations

The impact of the apelinergic system in coronary collateral formation

İbrahim Özsoyler et al. Turk Gogus Kalp Damar Cerrahisi Derg. .

Abstract

Background: This study aims to examine the relationship between the development of coronary collateral circulation and serum elabela levels.

Methods: Between January 2020 and December 2021, a total of 50 control individuals (29 males, 21 females; mean age: 63.2±10.0 years; range, 52 to 73 years) with no significant coronary artery disease as confirmed by angiography (Group 1) and 100 patients (55 males, 45 females; mean age: 66.6±9.6 years; range, 56 to 75 years) with coronary artery disease were included. The patients were further divided into two equal groups according to the Rentrop classification as poor (Group 2) and good coronary collateral circulation (Group 3). All groups were compared in terms of several parameters, particularly serum elabela levels.

Results: Serum elabela levels were found to be statistically higher in the group with good collateral than the other groups (p<0.05). Low serum elabela levels increased the risk of developing weak collaterals by 2.43 times.

Conclusion: The elabela protein is directly related to good collateral development and can be considered a potential agent for treatment.

Keywords: Apelinergic system; coronary artery disease; coronary collateral; elabela.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

References

    1. Seiler C, Stoller M, Pitt B, Meier P. The human coronary collateral circulation: Development and clinical importance. Eur Heart J. 2013;34:2674–2682. doi: 10.1093/eurheartj/eht195. - DOI - PubMed
    1. Seiler C. The human coronary collateral circulation. Eur J Clin Invest. 2010;40:465–476. doi: 10.1111/j.1365-2362.2010.02282.x. - DOI - PubMed
    1. Perjés Á, Kilpiö T, Ulvila J, Magga J, Alakoski T, Szabó Z, et al. Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart. Basic Res Cardiol. 2016;111:2–2. doi: 10.1007/s00395-015-0521-6. - DOI - PubMed
    1. Yang P, Read C, Kuc RE, Buonincontri G, Southwood M, Torella R, et al. Elabela/Toddler is an endogenous agonist of the apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of Its expression in pulmonary arterial hypertension. Circulation. 2017;135:1160–1173. doi: 10.1161/CIRCULATIONAHA.116.023218. - DOI - PMC - PubMed
    1. Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM, Smith CC. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury. Basic Res Cardiol. 2007;102:518–528. doi: 10.1007/s00395-007-0671-2. - DOI - PubMed

LinkOut - more resources